πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6251903

Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use there

The Regents of the University of California Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251878

Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotectiv

The Board of Regents of the University of Texas System Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251871

P16 expression constructs and their application in cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251861

Treatment of cerebral infarction using cyclic hexapeptides

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251858

Derivatives of oligosides, their process of preparation and their applications

I.D.M. Immuno-Designed Molecules Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251396

Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic pr

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251362

Method of establishing the optimal radiation dose

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251924

Pharmaceutical composition

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248888

Process for the preparation of terazosin hydrochloride dihydrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248791

Stimulating the differentiation of preadipocytic cells and therapies based thereon

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248749

Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acu

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248740

Condensed pyridazine derivatives, their production and use

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248528

Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

The Regents of the University of California Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248357

Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubilit

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245362

Medication for treatment of viral disease based on active agents of plant hypericum (St. J

Dreluso Pharmazeutika Dr. Elten & Sohn GmbH Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245899

Composition for detection of cell density signal molecule

The Regents of the University of California Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245892

Invaplex from gram negative bacteria, method of purification and methods of use

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245752

Compositions and methods for tolerization in immune complex-mediated disease progression

BioCrystal, Ltd. Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245563

Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxi

Maxim Pharmaceuticals, Inc. Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245560

Vector with multiple target response elements affecting gene expression

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245351

Controlled-release composition

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6242473

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. Β· Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6242486

Long chain carboxybetaines in antimicrobial formulations

Integrated Research Technology, LLC Β· Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6242482

Prostaglandin compounds and derivatives thereof, compositions containing the same and meth

United Therapeutics Corporation Β· Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired